Platelet-serotonin Dynamics: Elucidating Their Role in Pulmonary Arterial Hypertension
F Mindubayeva, M Ospanova… - Journal of Clinical …, 2024 - clinmedkaz.org
Background and Objectives: Pulmonary arterial hypertension (PAH) is a significant
complication in pediatric patients with congenital heart disease (CHD). The role of platelets …
complication in pediatric patients with congenital heart disease (CHD). The role of platelets …
Serum Copeptin Level as a Predictor Marker of Pediatric Heart Failure Outcomes
AA Abdelaziz, AA Khattab, MH Abdelmaksoud… - 2021 - researchsquare.com
Background: This study aimed to assess the role of copeptin as a diagnostic marker of heart
failure (HF) and outcomes. Method: We randomly recruited 76 cardiac patients aged 1 …
failure (HF) and outcomes. Method: We randomly recruited 76 cardiac patients aged 1 …
Biomarkers in Pulmonary Arterial Hypertension
SE Hojda, IC Chis, S Clichici - Chest, 2004 - europepmc.org
Pulmonary arterial hypertension (PAH) is a severe medical condition characterized by
elevated pulmonary vascular resistance (PVR), right ventricular (RV) failure, and death in …
elevated pulmonary vascular resistance (PVR), right ventricular (RV) failure, and death in …